• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    146.27 Up 1.71(1.18%) Jul 31, 4:00PM EDT
    |After Hours : 146.27 0.00 (0.00%) Jul 31, 4:22PM EDT
    Add to Portfolio
    Prev Close:144.56
    Open:145.44
    Bid:118.25 x 1000
    Ask:240.00 x 100
    1y Target Est:149.53
    Beta:1.09
    Next Earnings Date: 3-Aug-15BMRN Earnings announcement
    Day's Range:144.02 - 148.10
    52wk Range:61.64 - 151.75
    Volume:1,120,575
    Avg Vol (3m):1,310,440
    Market Cap:23.45B
    P/E (ttm):N/A
    EPS (ttm):-1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 1.18%23.45B
    FOLDUp 4.88%1.99B
    SHPGUp 1.63%52.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.13
    Quarterly EPS Est (Jun-15) :-0.53
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-2.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback